Treating Social Anxiety Disorders with Brain Hormones
- Details
- Category: Technological offers
-
18 Jun 2024
![](/images/resized/images/ahmed-nishaath-t0h7utrnaq0-unsplash-copia_250_150.jpg)
A team from the Institute of Neurosciences in Alicante (CSIC - UMH) has developed and patented a treatment for social disorders, such as anxiety or extreme introversion. It is based on the use of hormones that the brain naturally produces and which, as they have discovered, can regulate behavioral responses related to social interaction.
Lithium Nanocapsules for Cancer Treatment via Neutron Capture Therapy
- Details
- Category: Technological offers
-
10 Jun 2024
![](/images/resized/images/highlight_tobias_copia_120_120.png)
A team from the Institute of Materials Science of Barcelona (ICMAB) of the CSIC has developed carbon nanocapsules filled with enriched lithium compounds, which can be applied in Neutron Capture Therapy (NCT) for cancer treatment. They are now seeking industrial partners to continue the already patented development.
Obtaining three-dimensional cell cultures by ultrasound for in vitro studies
- Details
- Category: Technological offers
-
19 Feb 2024
![](/images/resized/images/esferoide-celulas-mesotelioma-wikipedia_120_120.jpg)
A team from ITEFI CSIC has developed an ultrasound system that allows the generation of cellular clusters in the form of spheres for in vitro studies. It enables the straightforward creation of stable three-dimensional cell cultures in just a few minutes.
Canine leishmaniasis vaccine developed by CSIC and Zendal reaches the market
- Details
- Category: Success stories
-
29 Apr 2024
![](/images/resized/images/fase-intracelular-parasito-leishmania-en-celulas-de-medula-osea-perro-cib-csic_120_120.jpg)
The Neoleish vaccine, with the participation of the Margarita Salas Biological Research Centre (CIB-CSIC), prevents infection and reduces the presence of the parasite by more than 90%.
A platform to boost therapeutic modified oligonucleotides
- Details
- Category: Projects
-
12 Feb 2024
![](/images/resized/images/xna-hub-image-fondo-negro_120_120.jpg)
They are one of the most promising pharmacological tools, custom-designed for diseases such as Alzheimer's, various types of cancer, or multiple sclerosis. A multicenter project, with the participation of the CSIC, aims to create the XNA-HUB platform for designing new therapeutic molecules based on modified nucleic acids. For doing this, the platform will utilize supercomputing techniques and predictive models of Artificial Intelligence.